121 related articles for article (PubMed ID: 31919692)
21. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V
Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092
[TBL] [Abstract][Full Text] [Related]
22. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.
Sellers TA; Mink PJ; Cerhan JR; Zheng W; Anderson KE; Kushi LH; Folsom AR
Ann Intern Med; 1997 Dec; 127(11):973-80. PubMed ID: 9412302
[TBL] [Abstract][Full Text] [Related]
23. Hormone replacement therapy and lung cancer risk in Chinese.
Chen KY; Hsiao CF; Chang GC; Tsai YH; Su WC; Perng RP; Huang MS; Hsiung CA; Chen CJ; Yang PC;
Cancer; 2007 Oct; 110(8):1768-75. PubMed ID: 17879370
[TBL] [Abstract][Full Text] [Related]
24. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study.
Feigelson HS; Jonas CR; Teras LR; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):220-4. PubMed ID: 14973094
[TBL] [Abstract][Full Text] [Related]
25. Oral contraceptives, hormone replacement therapy and breast cancer risk: a cohort study of 16 928 women 48 years and older.
Thorbjarnardottir T; Olafsdottir EJ; Valdimarsdottir UA; Olafsson O; Tryggvadottir L
Acta Oncol; 2014 Jun; 53(6):752-8. PubMed ID: 24460068
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Katki HA; Kovalchik SA; Berg CD; Cheung LC; Chaturvedi AK
JAMA; 2016 Jun; 315(21):2300-11. PubMed ID: 27179989
[TBL] [Abstract][Full Text] [Related]
27. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
28. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
[TBL] [Abstract][Full Text] [Related]
29. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
Liu JY; Chen TJ; Hwang SJ
Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
[TBL] [Abstract][Full Text] [Related]
30. Hormone replacement therapy in relation to risk of cataract extraction: a prospective study of women.
Lindblad BE; Håkansson N; Philipson B; Wolk A
Ophthalmology; 2010 Mar; 117(3):424-30. PubMed ID: 20045566
[TBL] [Abstract][Full Text] [Related]
31. Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers.
Kotsopoulos J; Gronwald J; Karlan BY; Huzarski T; Tung N; Moller P; Armel S; Lynch HT; Senter L; Eisen A; Singer CF; Foulkes WD; Jacobson MR; Sun P; Lubinski J; Narod SA;
JAMA Oncol; 2018 Aug; 4(8):1059-1065. PubMed ID: 29710224
[TBL] [Abstract][Full Text] [Related]
32. Prediagnostic BMI and thyroid cancer incidence in the PLCO trial.
Abdel-Rahman O
Future Oncol; 2019 Oct; 15(30):3451-3456. PubMed ID: 31646903
[No Abstract] [Full Text] [Related]
33. Sociodemographic and clinical factors associated with HRT use in women attending menopause clinics in Italy.
Pansini F; Bacchi Modena AB; de Aloysio D; Gambacciani M; Meschia M; Parazzini F; Sciacchitano G; di Micco R; Peruzzi E; Maiocchi G;
Climacteric; 2000 Dec; 3(4):241-7. PubMed ID: 11910583
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality.
O'Meara ES; Rossing MA; Daling JR; Elmore JG; Barlow WE; Weiss NS
J Natl Cancer Inst; 2001 May; 93(10):754-62. PubMed ID: 11353785
[TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
37. Use of hormone replacement therapy before and after ovarian cancer diagnosis and ovarian cancer survival.
Mascarenhas C; Lambe M; Bellocco R; Bergfeldt K; Riman T; Persson I; Weiderpass E
Int J Cancer; 2006 Dec; 119(12):2907-15. PubMed ID: 16998830
[TBL] [Abstract][Full Text] [Related]
38. Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort.
Krabbe LM; Svatek RS; Shariat SF; Messing E; Lotan Y
Urol Oncol; 2015 Feb; 33(2):65.e19-25. PubMed ID: 25044253
[TBL] [Abstract][Full Text] [Related]
39. Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population.
Christensen CH; Rostron B; Cosgrove C; Altekruse SF; Hartman AM; Gibson JT; Apelberg B; Inoue-Choi M; Freedman ND
JAMA Intern Med; 2018 Apr; 178(4):469-476. PubMed ID: 29459935
[TBL] [Abstract][Full Text] [Related]
40. Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis.
Burkard T; Rauch M; Spoendlin J; Prieto-Alhambra D; Jick SS; Meier CR
Maturitas; 2020 Feb; 132():17-23. PubMed ID: 31883658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]